Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Heterozygous Men1(+/T) Knockout Mice Do Not Develop Bronchopulmonary Neuroendocrine Hyperplasia or Neoplasia but Bronchial Adenocarcinoma.
Journal: Advances in respiratory medicine
Published: February 06, 2025
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?
Journal: Oncology (Williston Park, N.Y.)
Published: November 21, 2024
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?
Journal: Oncology (Williston Park, N.Y.)
Published: November 21, 2024
Hydroxypropyl β cyclodextrins effects on self-assembly of cyclic peptide, lanreotide acetate, in water and subsequent release rate from an in vitro emulator of subcutaneous delivery.
Journal: Journal of pharmaceutical sciences
Published: September 13, 2024
β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide.
Journal: Journal of pharmaceutical sciences
Published: September 05, 2024
Grade 3 Pancreatic Neuroendocrine Tumor Refractory to Chemotherapy Successfully Treated with Peptide Receptor Radionuclide Therapy Leading to Conversion Surgery.
Journal: Internal medicine (Tokyo, Japan)
Published: July 24, 2024
On-resin synthesis of Lanreotide epimers and studies of their structure-activity relationships.
Journal: RSC medicinal chemistry
Published: May 09, 2024
Lanreotide versus placebo for tumour reduction in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): a randomised, multicentre, phase 3 trial with blinded outcome assessment.
Journal: The Lancet regional health. Europe
Published: October 05, 2023
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 15, 2023
An international simulated-use study to assess nurses' preferences between two lanreotide syringes for patients with neuroendocrine tumours or acromegaly (PRESTO 3).
Journal: Journal of endocrinological investigation
Published: April 18, 2023
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
Journal: Advances in therapy
Published: September 12, 2022
Last Updated: 10/31/2025